The May issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin Cancer, with special features on Public Health, Atopic Dermatitis, Psoriasis, and…
Read More
IncobotulinumtoxinA (Xeomin/Xeomeen/Bocouture/XEOMIN Cosmetic; botulinum toxin type A free from complexing proteins ; Merz Pharmaceuticals GmbH) is indicated worldwide for the correction of glabellar frown lines (GFL) and in Europe additionally…
Read More
Photo: dimid_86 / Getty ImagesCurrent in-office laser and light-based hair removal devices effectively provide a long-term solution for unwanted hair removal.1 These in-office systems generally use high energies to deliver…
Read More
Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update
1 CME CreditSince initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of…
Read More
Melatonin is one of the latest trendy skincare ingredients that supposedly helps restore and improve skin tone, while helping to combat signs of aging. While the hormone helps improve the…
Read More
Emily C. Murphy BS, Kamaria Nelson MD, and Adam J. Friedman MD In a new article, published in the May 2020 issue of the JDD, "The Influence of Dermatologists' Use…
Read More
This webinar was previously recorded on April 27th, 2020 and is now available on demand. Skin of Color Update (SOCU) and JDD invite you to attend “COVID-19: Special Considerations for…
Read More
Next Steps in Derm COVID-19 News & Resources Center offers a carefully curated selection of relevant news and resources from truthworthy sources to help physicians navigate the COVID-19 pandemic.
Read More
JDD, Derm In-Review and GW invite you to join Dermatology colleagues and as we answer resident concerns during the global coronavirus pandemic. Discussions include the date of the boards, being…
Read More
Sponsored By This webinar was broadcasted on April 7th, 2020. Almirall has graciously supported the on-demand broadcast of this webinar. Join Dermatology colleagues and thought leaders as we examine the…
Read More
Sponsored By This webinar was previously recorded on April 1st, 2020 and is now available on demand. Almirall has graciously supported the on-demand broadcast of this webinar. JDD invites you…
Read More
Psoriasis is a chronic, immune-mediated disease that mainly affects the skin and joints. Treatment for psoriasis depends on the severity, along with many other factors, and limited psoriasis can often…
Read More
